Posts by tag

Pharma Marketing

96 posts

Cost of Incentives to Work Life Balance – Asrar Qureshi’s Blog Post #1258

Asrar Qureshi’s Blog Post 1257 discusses the impact of performance incentives in the pharmaceutical industry. While rewards drive productivity, they can also lead to work-life imbalance, burnout, and a narrow definition of success, emphasizing metrics over well-being. The post advocates for redesigning incentives to promote sustainable practices and prioritize employee wellness.
Share
View Post
  • 6 min

Doctors & Pharma Industry – Part 2 of 2 – Asrar Qureshi’s Blog Post #1218

Asrar Qureshi’s Blog Post #1218 addresses the complex relationship between pharmaceutical companies and doctors, emphasizing the need for ethical conduct in Pakistan’s healthcare system. It outlines a Code of Conduct for both sectors, aiming to balance industry collaboration with patient welfare, maintaining professionalism while avoiding conflicts of interest.
Share
View Post
  • 5 min

Doctors & Pharma Industry – Part 1 of 2 – Asrar Qureshi’s Blog Post 1217

The blog post by Asrar Qureshi explores the complex relationship between pharmaceutical companies and doctors, emphasizing its dual nature of necessity and ethical risk. It advocates for transparency and independence in education, particularly in the context of Pakistan’s healthcare challenges. The post highlights both issues and contributions of this relationship in improving patient access to treatment.
Share
View Post
  • 5 min

Pharma Marketing by 2030 – Asrar Qureshi’s Blog Post #1148

Asrar Qureshi’s Blog Post #1148 outlines anticipated changes in pharmaceutical marketing by 2030, emphasizing a hybrid omnichannel approach and AI integration in sales. The role of Medical Affairs will grow, and compliance will become real-time. In Pakistan, increased digital engagement and regulatory improvements will shape marketing strategies, enhancing patient support programs.
Share
View Post
  • 5 min

Ten Tests of Strategy by McKinsey – Asrar Qureshi’s Blog Post #1136

Asrar Qureshi’s blog discusses the importance of effective strategy formulation in corporates. It highlights McKinsey’s “10 Timeless Tests” to rigorously evaluate strategies, ensuring they are robust and capable of outperforming the market. The tests focus on identifying competitive advantages, segment analysis, and adapting to trends, emphasizing actionable commitments for success.
Share
View Post
  • 5 min

Recent Drug Safety Alerts – Asrar Qureshi’s Blog Post #1125

Asrar Qureshi’s Blog Post 1125 discusses post-marketing surveillance and pharmacovigilance efforts in reporting adverse drug reactions. It highlights recent FDA warnings about cetirizine, scopolamine patches, and mRNA COVID-19 vaccines concerning severe side effects, urging that this information be treated as essential for discussions among healthcare professionals.
Share
View Post
  • 4 min

Pharmaceutical Marketing – Stuck in the Past – Asrar Qureshi’s Blog Post #1103

The blog post discusses the stagnation of pharmaceutical marketing due to reliance on outdated strategies, regulatory constraints, and risk aversion. It emphasizes the need for innovation through data-driven personalization, omnichannel engagement, and agile methodologies. A cultural shift toward collaboration and customer-centric approaches is essential for modernization and relevance in a changing landscape.
Share
View Post
  • 5 min

AI and Machine Learning in Pharmaceutical Drug Development – Asrar Qureshi’s Blog Post #1102

The blog post by Asrar Qureshi discusses the transformative impact of Artificial Intelligence (AI) and Machine Learning (ML) on the pharmaceutical industry. It highlights innovations in drug discovery, preclinical development, clinical trials, and manufacturing, emphasizing efficiency and personalized medicine. However, challenges like data privacy and regulatory uncertainty must be addressed.
Share
View Post
  • 5 min

Influence of Gen AI on Pharmaceutical Marketing – Now and in Five Years – Asrar Qureshi’s Blog Post #1088

Asrar Qureshi’s blog discusses the transformative impact of Artificial Intelligence (AI) on pharmaceutical marketing, emphasizing its evolution towards more data-driven, personalized strategies. It highlights current capabilities, like AI in predictive analytics and content creation, while forecasting increased AI integration over the next five years, offering significant advantages to adaptable companies.
Share
View Post
  • 5 min

Pharma Marketing Over Decades– Asrar Qureshi’s Blog Post #1079

Asrar Qureshi’s blog discusses the transformation of pharmaceutical marketing, highlighting a shift from sales-driven approaches to patient-centric strategies. While global trends favor digital engagement and direct-to-consumer marketing, Pakistan remains reliant on traditional methods. Greater compliance and ethical engagement are necessary to modernize the industry and meet evolving patient expectations.
Share